Investing for the Long-Run: Positive Signs for CME Group Inc. (CME)

Pankau Ronald A., Director, subtracted 300 shares of CME Group Inc. (CME) from its portfolio at the rate of $199.02 per share valuing $59,706 on Nov 07. The insider left behind 3,906 shares of the company to its portfolio. Currently, the 1st Resistance Point for this stock is $205.14, with a 2nd Resistance Point sitting at $206.96. Meanwhile, this company’s stock has a 1st Support Level at $201.76 and a 2nd Support Level at $200.20. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of CME Group Inc. (CME) was $203.32. CME Group Inc. (CME) stock has lost -$3.58, or -1.68%, in the past five days. In the last full month, these shares have gained $1.81, or 0.90%. In the past three months, this stock’s price has fallen by -$13.97, or -6.43%. This year-to-date, CME Group Inc. (CME) shares have gained $15.20, or 8.08%.

Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For CME Group Inc. (CME) stock, Hold % of short-term indicators suggest that these shares are a “ Sell .” Meanwhile, Hold % of medium-term indicators point to this stock being a “.” Looking further ahead, 50% of long-term indicators suggest that this stock is a “ Buy .”

With 358,363 K shares outstanding, this company currently has a market capitalization of $72,650,928K. CME Group Inc. (CME) generates $4,309 M in annual sales, amounting to annual net income of $1,962 M. This stock has generated a 1-Year Total Return of 6.97%, a 3-Year Total Return of 75.31%, and a 5-year Total Return of 128.45%. This stock’s 5-Year Dividend Growth is 3.41%, with its most recent dividend valued at $0.750 per share on 09/09/19. Its Annual Dividend Yield is 1.48%, and its Annual Dividend Rate is 3.00.

In the most recently-reported fiscal quarter, which ended in 09/19, CME Group Inc. (CME) reported earnings of $1.90 per share. Wall Street analysts, on average, were expecting the company to report earnings of $1.75 per share, representing a 0.15 difference and 8.57% surprise. In the previous quarter ending in 06/19, the reported earnings of $1.76 represented a 0.01 difference from the consensus estimate calling for $1.75 per share, which was a 0.57% surprise.

For the current fiscal quarter, which is set to end in 12/2019, the average earnings estimate is $1.63 per share. This estimate came from a total of 6 Wall Street Analysts. Of those market experts, the high estimate was $1.71 and the low estimate was $1.53. In the year-ago quarter, CME Group Inc. (CME) generated per-share earnings of $1.77. If the analysts are correct about the current quarter’s earnings, the growth will be -7.91%.

Turning our focus now to insider trading activity, there have been 13 purchases (50,805 shares in total) and 51 sale (39,464 shares in total) in the last 3 months. In the last 6 months, there have been 37 insider buys amounting to 85,162 shares and 72 insider sales amounting to 121,742 shares. In the past full year, 71 insider purchases were made (involving 244,073 shares) and 131 insider sell-offs equivalent to 263,552 shares.

Looking at this company’s capital structure, its Total Debt to Total Equity is 16.98, its Total Debt to Total Capital is 14.52, and its Total Debt to Total Assets is now 5.68. Looking even further ahead into the future, its Long-Term Debt to Equity is 16.64 and its Long-Term Debt to Total Capital is 14.76.